Analgesic and anti-inflammatory actions of robenacoxib in acute joint inflammation in dog

The objectives of this study were to establish dose-response and blood concentration-response relationships for robenacoxib, a novel nonsteroidal anti-inflammatory drug with selectivity for inhibition of the cyclooxygenase (COX)-2 isoenzyme, in a canine model of synovitis. Acute synovitis of the stifle joint was induced by intra-articular injection of sodium urate crystals. Robenacoxib (0.25, 0.5, 1.0, 2.0 and 4.0 mg/kg), placebo and meloxicam (0.2 mg/kg) were administered subcutaneously (s.c.) 3 h after the urate crystals. Pharmacodynamic endpoints included data from forceplate analyses, clinical orthopaedic examinations and time course of inhibition of COX-1 and COX-2 in ex vivo whole blood assays. Blood was collected for pharmacokinetics. Robenacoxib produced dose-related improvement in weight-bearing, pain and swelling as assessed objectively by forceplate analysis (estimated ED(50) was 1.23 mg/kg for z peak force) and subjectively by clinical orthopaedic assessments. The analgesic and anti-inflammatory effects of robenacoxib were significantly superior to placebo (0.25-4 mg/kg robenacoxib) and were non-inferior to meloxicam (0.5-4 mg/kg robenacoxib). All dosages of robenacoxib produced significant dose-related inhibition of COX-2 (estimated ED(50) was 0.52 mg/kg) but no inhibition of COX-1. At a dosage of 1-2 mg/kg administered s.c., robenacoxib should be at least as effective as 0.2 mg/kg of meloxicam in suppressing acute joint pain and inflammation in dogs.

Zerstörung der Hornanlage beim Kalb – Literaturübersicht – das Schweizer Modell

In Deutschland werden jährlich die Hornanlagen von geschätzten 2,5 Mio. Kälbern zerstört. Dies ist bei Kälbern bis zum Alter von sechs Wochen ohne Anästhesie erlaubt, obwohl der Eingriff nachweislich starke Schmerzen verursacht. Der vorliegende Artikel fasst das aktuelle Wissen zum Thema zusammen und beschreibt die gesetzlichen Vorgaben anderer Länder zur Schmerzausschaltungspflicht. Weiterhin werden erstmals die Resultate einer aktuellen Umfrage bei allen Nutztierpraktikern (Rückantwortrate 40 %) in der Schweiz aus dem Jahr 2012 zur Delegation der Schmerzausschaltung an Tierhaltende vorgestellt. Auf Grund der aktuellen Literatur wird im Fall, dass auf die Zerstörung der Hornanlage nicht verzichtet werden kann, folgendes Vorgehen empfohlen: Die Hornanlage soll in den ersten 21 Lebenstagen des Kalbes, frühestens 10 Minuten nach Setzen einer Lokalanästhesie mit je 5 ml Procain 2 % pro Seite (Anästhesie des R. cornualis rechts und links) durch lokale Applikation von Hitze mit einem geeigneten Brennstab zerstört werden. Gleichzeitig zur Lokalanästhesie soll Meloxicam (einmalige Injektion von 0,5 mg/kg KGW; subkutan oder intravenös) appliziert werden. Die Einführung einer generellen Schmerzausschaltungsplicht bei der Zerstörung der Hornanlage von Kälbern ist aus Sicht des Tierwohls äußerst wünschenswert. In Deutschland ist heute die Schmerzausschaltung ohne Arzneimittelumwidmung möglich. Seit 2005 ist in der Schweiz die Schmerzausschaltung Pflicht, und seit 2008 besteht die Möglichkeit, die Anästhesie zur Zerstörung der Hornanlage bei Kälbern bis zum Alter von drei Wochen an den ausgebildeten Tierhalter zu delegieren. In allen landwirtschaftlichen Betrieben, welche von 52 % der tierärztlichen Praxen betreut werden, wird heute aus Sicht der antwortenden Nutztierpraktiker keine Zerstörung der Hornanlage bei Kälbern mehr ohne Anästhesie durchgeführt. Eine überwiegende Mehrheit dieser Tierärzte lehnt die Delegationsmöglichkeit der Schmerzausschaltung an Tierhalter nicht ab. Dies zeigt auf, dass dieses Modell eine erfolgversprechende Strategie darstellt, welche gegebenenfalls auch von anderen Ländern zur Umsetzung einer gesetzlich vorgeschriebenen Schmerzausschaltungspflicht in Betracht gezogen werden könnte.

Attitudes of Swiss veterinarians towards pain and analgesia in dogs and cats.

A survey was performed to evaluate the use of perioperative analgesia in dogs and cats by veterinary practitioners. Questions were grouped in seven sections recording personal data, education in veterinary analgesia, general ideology regarding treatment of perioperative pain, personal experience, assessment, and use of main analgesics to treat perioperative pain. A total of 258 received forms were analyzed. Based on 5 questions, 88 % showed excellent motivation to use perioperative pain therapy. The main reason declared for the use of analgesics was to relieve the patient from pain (64.1 %). Most veterinarians reported to routinely administer analgesics before (71 - 96 %) or after (2 - 23 %) surgery. The most used analgesics were non-steroidal anti-inflammatory drugs (carprofen, meloxicam) and opioids (butorphanol, buprenorphine). Animals were routinely evaluated for pain after recovery. Only 43.8 % of veterinarians declared to use loco-regional anaesthesia. Swiss veterinarians appear to recognize well the need for perioperative pain treatment. However, weakness was shown in evaluating pain severity, distinguishing between opioid classes, and using loco-regional anaesthesia.

Drug-induced bilateral transient myopia with the sulphonamide sulphasalazine

Whereas there are numerous reported ocular side effects from systemic sulpha medication, most are rare and reversible, with myopia being the most common reaction observed. A case report is presented of sudden bilateral onset of -1.0 DS of myopia (from -3.0 to -4.0 DS) in a young adult female following the addition of a sulphonamide (sulphasalazine) to oral non-steroidal anti-inflammatory treatment (meloxicam) for rheumatoid arthritis. The myopia regressed to -3.50 DS after 2 weeks when all medication was withdrawn and stabilised at this level when subsequent treatment was resumed after 8 weeks with the non-steroidal anti-inflammatory drug celecoxib. The case indicates that account needs to be taken of the possibility that relatively modest myopic shifts encountered in young adult contact lens wearers may be associated with concomitant systemic medication. © 2003 The College of Optometrists.

Evaluation of hemosponge in promoting dental socket healing after 3rd mandibular premolar extraction in a feline model

Aim: To investigate the healing process following use of collagen sponges in the dental socket after extraction. Wound complications during the study were also evaluated. Methods: 32 cats were included in this study. IV administration of the combination of diazepam (0.22 mg/kg) and ketamine (10 mg/kg) was used to induce general anesthesia. Surgical extraction of both 3rd mandibular premolars was performed. The open dental sockets were divided in two groups. In Group A, the open dental socket on the left side was closed using 4-0 Monocryl in simple interrupted pattern. In Group B, the right dental socket was filled with lyophilized hydrolyzed collagen and the buccal and lingual flaps were sutured using 4-0 Monocryl and simple interrupted pattern. Meloxicam (0.2 mg/kg) was used to manage the post-extraction pain in all cats. Ampicilline 20 mg/kg was used as prophylaxis. The wounds were observed during the study to evaluate any signs of inflammation or dehiscence. Radiographs were taken to compare healing of the socket 3 weeks after the procedure. A 1 mm biopsy punch sample was taken from sockets in all cats for comparison of the healing in both groups. Results: Hemorrhage occurred only in the sockets of Group A. Remission of radiolucent area occurred in both groups. Mean score of inflammation was lower and mean scores of fibrotic reaction and fibroplasia were higher in Group B (p<0.05). Conclusions: Use of hemosponge in alveolar socket may accelerate fibroplasia and formation of the connective tissue and reduce inflammation after tooth extraction. Therefore, post-extraction use of the hemostatic agent in the dental socket is recommended.

Avaliação dos efeitos secundários induzidos pela administração oral de ciclofosfamida em regime de quimioterapia metronómica em cães e gatos : estudo retrospetivo de 36 casos

Dissertação de Mestrado Integrado em Medicina Veterinária